Nanjing Vazyme Biotech Co Ltd Class A 688105
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 25.48
- Day Range
- CNY 25.06–25.54
- 52-Week Range
- CNY 17.58–41.49
- Bid/Ask
- CNY 25.41 / CNY 25.42
- Market Cap
- CNY 10.16 Bil
- Volume/Avg
- 1.4 Mil / 2.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7.87
- Dividend Yield (Trailing)
- 4.86%
- Dividend Yield (Forward)
- 4.86%
- Total Yield
- 4.91%
Company Profile
Nanjing Vazyme Biotech Co Ltd is a biotechnology company. It is committed to research and development both in technology and products focusing on functional proteins, such as enzymes, antigens, antibodies, and polymer organic materials.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Value
- Total Number of Employees
- 2,700
- Website
- http://www.vazyme.com
Comparables
Valuation
|
Metric
|
688105
|
301080
|
688266
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 35.94 | — |
Price/Book Value | 2.55 | 1.92 | 9.29 |
Price/Sales | 7.87 | 9.11 | 37.89 |
Price/Cash Flow | 56.00 | 50.56 | — |
Price/Earnings
688105
301080
688266
Financial Strength
|
Metric
|
688105
|
301080
|
688266
|
|---|---|---|---|
Quick Ratio | 2.92 | 13.32 | 2.10 |
Current Ratio | 3.27 | 14.50 | 2.25 |
Interest Coverage | −1.55 | 32.07 | −11.79 |
Quick Ratio
688105
301080
688266
Profitability
|
Metric
|
688105
|
301080
|
688266
|
|---|---|---|---|
Return on Assets (Normalized) | −3.59% | 4.53% | −12.23% |
Return on Equity (Normalized) | −5.04% | 4.86% | −21.86% |
Return on Invested Capital (Normalized) | −4.02% | 2.83% | −14.22% |
Return on Assets
688105
301080
688266
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Sdvcdmhqhh | Jclx | $586.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Qdphqzzdx | Rccpnn | $110.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Rhbcgnk | Kgqwv | $107.6 Bil | |
MRNA
| Moderna Inc | Chjrdlhl | Kcr | $48.2 Bil | |
BNTX
| BioNTech SE ADR | Qwzflwxfh | Rxgjh | $22.2 Bil | |
ARGX
| argenx SE ADR | Zmhbtfhd | Hkxf | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Nccntmklt | Qtqpjv | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Jhxqtphm | Lxygrr | $15.1 Bil | |
INCY
| Incyte Corp | Qtggnbxy | Czbywjv | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Nzgfrvrgc | Phhqds | $12.7 Bil |